Vorasidenib Alternatives Compared
| Vorasidenib | Voranigo (vorasidenib) | Bevacizumab |
|
|---|
| Vorasidenib | Voranigo (vorasidenib) | Bevacizumab |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Malignant Glioma. Vorasidenib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Malignant Glioma. Voranigo may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glioblastoma Multiforme, Colorectal Cancer, Cervical Cancer, Fallopian Tube Cancer, Breast Cancer, Breast Cancer - Metastatic, Hepatocellular Carcinoma, Macular Degeneration, Malignant... View more |
Related suggestions Malignant Glioma
|
|||||||
| More about Vorasidenib | More about Voranigo (vorasidenib) | More about Bevacizumab | ||||||||
| Ratings & Reviews | ||||||||||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Bevacizumab has an average rating of 7.6 out of 10 from a total of 37 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
|
View all Vorasidenib side effects |
View all Voranigo side effects |
View all Bevacizumab side effects |
||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Voranigo prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
|
N/A |
||||||||
| Brand Names | ||||||||||
| Voranigo |
N/A |
Alymsys, Avastin, Avzivi, Jobevne, Mvasi, Vegzelma, Zirabev | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
240 hours |
240 hours |
480 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 436 drugs are known to interact with Vorasidenib:
|
A total of 436 drugs are known to interact with Voranigo:
|
A total of 50 drugs are known to interact with Bevacizumab:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
August 06, 2024 |
August 06, 2024 |
N/A |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
|
||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.